Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Aetna - Caught on Camera

ARS Pharmaceuticals Q1 Earnings Call Highlights

ARS Pharmaceuticals (NASDAQ:SPRY) reported first-quarter 2026 revenue of $22.7 million as executives said the company is working to expand access, reduce prescribing friction and build momentum for neffy, its needle-free epinephrine treatment for allergic reactions including anaphylaxis. Co-founder

MarketBeat

AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam

AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are expected to be positive but have not yet been quantified. Speaking during a company event, Dale said he w

MarketBeat

Slow-Moving CVS Health (CVS) Stock Could Offer a Surprise for Bullish Options Traders

While CVS stock hasn’t exactly enjoyed an auspicious start to the new year, the market appears to have flashed an intriguing setup.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Man arrested inside Aetna’s headquarters with AR-style pistol in backpack

A man walking into health insurer Aetna’s headquarters with an AR-style pistol in his backpack was detained by security without incident Thursday morning, police said.

The Independent UK

Two physicians on ending the waiting-room era: bring care home

Aetna CMO Benjamin Kornitzer and former Senate Majority Leader Bill Frist on why home-based care for America's sickest seniors isn't a vision anymore.

Fortune

Anchorage Doctor Finally Jailed in Shocking $12M Scam After Multiple Healthcare Fraud Schemes

An Anchorage doctor is jailed after a $12M healthcare fraud scheme involving fake treatments, underdosing patients, and tax evasion.

International Business Times UK

Attorney Charged in $500K Extortion Plot, Allegedly Threatened Client's Son

A New York attorney faces charges for allegedly attempting to extort $500,000 from a former client and his son, involving threats and intimidation.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

Adobe Hit With $150M Settlement Over Hard-to-Cancel Subscription Scandal

Adobe Inc. agrees to a $150 million settlement with the US government over allegations of misleading subscription practices, including hidden fees and complex cancellation processes.

International Business Times UK

Chevron Fined $1M Over Clean Air Act Breach, Millions in Renewable Fuel Credits Scrapped

Chevron agrees to pay a $1M penalty after violating the Clean Air Act's Renewable Fuel Standard by generating invalid renewable fuel credits, the DOJ says.

International Business Times UK

US Insurance Giant Aetna Agrees to $117.7M Settlement Over Medicare Advantage Fraud Claims

Aetna agrees to pay $117.7M to settle federal fraud allegations over inflated Medicare Advantage payments and diagnostic coding practices.

International Business Times UK

Feeling Frustrated With Your Medicare Advantage Plan? You’re Not Alone — Member Trust Is Falling

Medicare Advantage plans scored lower in overall satisfaction among members in 2025. Eroding trust and policy confusion drove the drop in customer satisfaction.

Kiplinger

Health Care Stocks Have Sagged. Can You Bet on a Recovery?

The flagging health care sector has perked up a bit lately. Is it time to invest?

Kiplinger

5 lessons about misinformation from ancient Greek and Roman scientists

Ancient scientists can be easy to dismiss.

The Conversation

‘It would be cheaper if I died:’ Cancer patients are battling insurance companies for their lives

IN FOCUS: EXCLUSIVE: Cancer patients, oncologists and advocates tell Rhian Lubin why the US health insurance system needs urgent reform, and is risking the lives of Americans fighting the disease

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

My health insurance company forced me to carry our last-chance IVF baby for a week after he died. Where’s the humanity?

IN FOCUS: EXCLUSIVE: 'I've already lost my baby and now this,’ a Nevada mother tells Rhian Lubin of the agony she endured after losing her son at 18 weeks, compounded by a health insurance company’s initial decision to deny her treatment in the hospital

Kiplinger

Major Insurers Scale Back Medicare Advantage and Part D Plans for 2026

Beneficiaries enrolled in Medicare Advantage and Part D prescription drug plans might be losing their plan as UnitedHealthcare, Humana, and Aetna (CVS Health) scale back offerings for 2026.

Benzinga

Aetna Expands Hospital Program To Cut Readmissions

Aetna, a CVS Health Inc. (NYSE:CVS) company, announced it will scale the Aetna Clinical Collaboration (ACC) program to ten hospitals by year-end, with implementations underway with AdventHealth Shawnee Mission, Houston Methodist, and WakeMed Health Hospitals.

Saving Advice

8 Insurance Companies Facing Lawsuits Over Denied Senior Claims

For millions of seniors, insurance is supposed to provide peace of mind—a safety net in times of medical need, long-term care, or financial uncertainty. But...

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Former CEO sentenced to prison for stock trades in milestone case

A lawyer for ex-Ontrak CEO and executive chairman Terren Peizer called the case a “true miscarriage of justice from the get-go.”

Fortune

Breakups between health systems and Medicare Advantage plans have increased. Sometimes, patients get to leave plans, too

It's usually challenging for patients to get out of Medicare Advantage. It can be easier if hospitals leave, first.

The Guardian - US

My $30,000 health insurance claim was denied. Then I tweeted about it

Public shaming works – but it’s also a sign of how broken the appeals process is in the US health insurance industry

MarketBeat

3 Beaten Down Healthcare Stocks Recovering in 2025

Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound.

Barchart

This Dividend Stock Is Up 45% in 2025. Is It Too Late to Buy Shares Now?

CVS stock has surged 45% in 2025, driven by strong Q4 earnings, a new CEO, and strategic innovations.

MarketBeat

Can Integrated Healthcare Stocks Succeed in Public Markets?

An integrated healthcare model sees healthcare providers merge with health insurers. While CVS Health proves it can't be done, UnitedHealth may prove it can.

The Conversation

What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices for everyone

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.